Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to IONIS-HTT Rx for the treatment of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results